Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 2
1989 2
1990 2
1991 6
1992 4
1993 8
1994 3
1995 7
1996 4
1997 7
1998 1
1999 4
2000 8
2001 7
2002 7
2003 5
2004 8
2005 11
2006 8
2007 4
2008 15
2009 7
2010 10
2011 5
2012 11
2013 15
2014 27
2015 20
2016 23
2017 16
2018 23
2019 17
2020 11
2021 15
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Results by year
Filters applied: . Clear all
Page 1
Protein Ubiquitination Research in Oncology.
Faktor J, Pjechová M, Hernychová L, Vojtěšek B. Faktor J, et al. Among authors: vojtesek b. Klin Onkol. 2019 Fall;32(Supplementum 3):56-64. doi: 10.14735/amko20193S. Klin Onkol. 2019. PMID: 31627707 Review. English.
STAT3, stem cells, cancer stem cells and p63.
Galoczova M, Coates P, Vojtesek B. Galoczova M, et al. Among authors: vojtesek b. Cell Mol Biol Lett. 2018 Mar 22;23:12. doi: 10.1186/s11658-018-0078-0. eCollection 2018. Cell Mol Biol Lett. 2018. PMID: 29588647 Free PMC article. Review.
TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation.
Iscan E, Ekin U, Yildiz G, Oz O, Keles U, Suner A, Cakan-Akdogan G, Ozhan G, Nekulova M, Vojtesek B, Uzuner H, Karakülah G, Alotaibi H, Ozturk M. Iscan E, et al. Among authors: vojtesek b. Cancers (Basel). 2021 Feb 13;13(4):783. doi: 10.3390/cancers13040783. Cancers (Basel). 2021. PMID: 33668566 Free PMC article.
Prima-1 and APR-246 in Cancer Therapy.
Zatloukalová P, Galoczová M, Vojtěšek B. Zatloukalová P, et al. Among authors: vojtesek b. Klin Onkol. 2018 Winter;31(Suppl 2):71-76. doi: 10.14735/amko20182S71. Klin Onkol. 2018. PMID: 31023027 Review. English.
[Protein expression and purification].
Růčková E, Müller P, Vojtěšek B. Růčková E, et al. Among authors: vojtesek b. Klin Onkol. 2014;27 Suppl 1:S92-7. doi: 10.14735/amko20141s92. Klin Onkol. 2014. PMID: 24945544 Review. Czech.
Mitochondrial Processes in Targeted Cancer Therapy.
Krejčíř R, Valík D, Vojtěšek B. Krejčíř R, et al. Among authors: vojtesek b. Klin Onkol. 2018 Winter;31(Suppl 2):14-20. doi: 10.14735/amko20182S14. Klin Onkol. 2018. PMID: 31023019 Review. English.
[Bioinformatics and Next -generation Sequencing].
Krejčí A, Müller P, Vojtěšek B. Krejčí A, et al. Among authors: vojtesek b. Klin Onkol. 2015;28 Suppl 2:2S91-6. doi: 10.14735/amko20152s91. Klin Onkol. 2015. PMID: 26374164 Review. Czech.
CRISPR-Cas9 as a Tool in Cancer Therapy.
Zatloukalová P, Krejčíř R, Valík D, Vojtěšek B. Zatloukalová P, et al. Among authors: vojtesek b. Klin Onkol. 2019 Fall;32(Supplementum 3):13-18. doi: 10.14735/amko20193S. Klin Onkol. 2019. PMID: 31627701 Review. English.
[Adenoviral Vectors in Gene Therapy].
Pjechová M, Hernychová L, Tomašec P, Wilkinson GW, Vojtěšek B. Pjechová M, et al. Among authors: vojtesek b. Klin Onkol. 2015;28 Suppl 2:2S75-80. doi: 10.14735/amko20152s75. Klin Onkol. 2015. PMID: 26374162 Review. Czech.
The Role of HSF1 Protein in Malignant Transformation.
Šimončík O, Pastorek M, Vojtěšek B, Müller P. Šimončík O, et al. Among authors: vojtesek b. Klin Onkol. 2018 Winter;31(Suppl 2):55-62. doi: 10.14735/amko20182S55. Klin Onkol. 2018. PMID: 31023025 Review. English.
312 results